|
1
|
Li XJ, Ren ZJ, Tang JH and Yu Q: Exosomal
microRNA miR-1246 promotes cell proliferation, invasion and drug
resistance by targeting CCNG2 in breast cancer. Cell Physiol
Biochem. 44:1741–1748. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang K, Huang Q, Qiu F and Sui M:
Non-viral delivery systems for the application in p53 cancer gene
therapy. Curr Med Chem. 22:4118–4136. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xiao J, Mu J, Liu T and Xu H: Dig the root
of cancer: Targeting cancer stem cells therapy. J Med Discov.
2:jmd170032017.
|
|
4
|
Madhavan M, Srinivas P, Abraham E, Ahmed
I, Vijayalekshmi NR and Balaram P: Down regulation of endothelial
adhesion molecules in node positive breast cancer: Possible failure
of host defence mechanism. Pathol Oncol Res. 8:125–128. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang W, Jin GQ, Liu JJ, Su DK, Luo NB,
Xie D, Lai SL, Huang XY and Huang WL: Diagnostic performance of
ADCs in different ROIs for breast lesions. Int J Clin Exp Med.
8:12096–12104. 2015.PubMed/NCBI
|
|
6
|
Silva HC, Garcao F, Coutinho EC, De
Oliveira CF and Regateiro FJ: Soluble VCAM-1 and E-selectin in
breast cancer: Relationship with staging and with the detection of
circulating cancer cells. Neoplasma. 53:538–543. 2006.PubMed/NCBI
|
|
7
|
Xu YC, Zhang FC, Li JJ, Dai JQ, Liu Q,
Tang L, Ma Y, Xu Q, Lin XL, Fan HB and Wang HX: RRM1, TUBB3, TOP2A,
CYP19A1, CYP2D6: Difference between mRNA and protein expression in
predicting prognosis of breast cancer patients. Oncol Rep.
34:1883–1894. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Luo P, Lu G, Fan LL, Zhong X, Yang H, Xie
R, Lv Z, Lv QZ, Fu D, Yang LX and Ma Y: Dysregulation of TMPRSS3
and TNFRSF11B correlates with tumorigenesis and poor prognosis in
patients with breast cancer. Oncol Rep. 37:2057–2062. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang L, Chen Z, Xue D, Zhang Q, Liu X,
Luh F, Hong L, Zhang H, Pan F, Liu Y, et al: Prognostic and
therapeutic value of mitochondrial serine
hydroxyl-methyltransferase 2 as a breast cancer biomarker. Oncol
Rep. 36:2489–2500. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Harris L, Fritsche H, Mennel R, Norton L,
Ravdin P, Taube S, Somerfield MR, Hayes DF and Bast RC Jr: American
Society of Clinical Oncology: American society of clinical oncology
2007 update of recommendations for the use of tumor markers in
breast cancer. J Clin Oncol. 25:5287–5312. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gyorffy B, Lanczky A, Eklund AC, Denkert
C, Budczies J, Li Q and Szallasi Z: An online survival analysis
tool to rapidly assess the effect of 22,277 genes on breast cancer
prognosis using microarray data of 1,809 patients. Breast Cancer
Res Treat. 123:725–731. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Koch AE, Halloran MM, Haskell CJ, Shah MR
and Polverini PJ: Angiogenesis mediated by soluble forms of
E-selectin and vascular cell adhesion molecule-1. Nature.
376:517–519. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gho YS, Kim PN, Li HC, Elkin M and
Kleinman HK: Stimulation of tumor growth by human soluble
intercellular adhesion molecule-1. Cancer Res. 61:4253–4257.
2001.PubMed/NCBI
|
|
14
|
Price JT and Thompson EW: Mechanisms of
tumour invasion and metastasis: Emerging targets for therapy.
Expert Opin Ther Targets. 6:217–233. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pauli BU, Augustin-Voss HG, el-Sabban ME,
Johnson RC and Hammer DA: Organ-preference of metastasis. The role
of endothelial cell adhesion molecules. Cancer Metastasis Rev.
9:175–189. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Byrne GJ, Ghellal A, Iddon J, Blann AD,
Venizelos V, Kumar S, Howell A and Bundred NJ: Serum soluble
vascular cell adhesion molecule-1: Role as a surrogate marker of
angiogenesis. J Natl Cancer Inst. 92:1329–1336. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sheen-Chen SM, Eng HL, Huang CC and Chen
WJ: Serum levels of soluble E-selectin in women with breast cancer.
Br J Surg. 91:1578–1581. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gutman M and Fidler IJ: Biology of human
colon cancer metastasis. World J Surg. 19:226–234. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
O'Hanlon DM, Fitzsimons H, Lynch J, Tormey
S, Malone C and Given HF: Soluble adhesion molecules (E-selectin,
ICAM-1 and VCAM-1) in breast carcinoma. Eur J Cancer. 38:2252–2257.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Menger MD and Vollmar B: Adhesion
molecules as determinants of disease: From molecular biology to
surgical research. Br J Surg. 83:588–601. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tesarova P, Kalousova M, Zima T, Suchanek
M, Malikova I, Kvasnicka J, Duskova D, Tesar V, Vachek J,
Krupickova-Kasalova Z and Malik J: Endotelial activation and
flow-mediated vasodilation in young patients with breast cancer.
Neoplasma. 60:690–697. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bewick M, Conlon M, Lee H, Parissenti AM,
Zhang L, Glück S and LaFrenie RM: Evaluation of sICAM-1, sVCAM-1
and sE-Selectin levels in patients with metastatic breast cancer
receiving high-dose chemotherapy. Stem Cells Dev. 13:281–294. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
McEver RP: Selectin-carbohydrate
interactions during inflammation and metastasis. Glycoconj J.
14:585–591. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bevilacqua MP, Pober JS, Mendrick DL,
Cotran RS and Gimbrone MA Jr: Identification of an inducible
endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci USA.
84:9238–9242. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Eichbaum MH, de Rossi TM, Kaul S and
Bastert G: Serum levels of soluble E-selectin are associated with
the clinical course of metastatic disease in patients with liver
metastases from breast cancer. Oncol Res. 14:603–610. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yasmin-Karim S, King MR, Messing EM and
Lee YF: E-selectin ligand-1 controls circulating prostate cancer
cell rolling/adhesion and metastasis. Oncotarget. 5:12097–12110.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Steinbach F, Tanabe K, Alexander J,
Edinger M, Tubbs R, Brenner W, Stöckle M, Novick AC and Klein EA:
The influence of cytokines on the adhesion of renal cancer cells to
endothelium. J Urol. 155:743–748. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Daneker GW, Lund SA, Caughman SW, Staley
CA and Wood WC: Anti-metastatic prostacyclins inhibit the adhesion
of colon carcinoma to endothelial cells by blocking E-selectin
expression. Clin Exp Metastasis. 14:230–238. 1996.PubMed/NCBI
|
|
29
|
Nguyen M, Corless CL, Kraling BM, Tran C,
Atha T, Bischoff J and Barsky SH: Vascular expression of E-selectin
is increased in estrogen-receptor-negative breast cancer: A role
for tumor-cell-secreted interleukin-1 alpha. Am J Pathol.
150:1307–1314. 1997.PubMed/NCBI
|
|
30
|
Narita T, Kawakami-Kimura N, Matsuura N,
Hosono J and Kannagi R: Corticosteroids and medroxyprogesterone
acetate inhibit the induction of E-selectin on the vascular
endothelium by MDA-MB-231 breast cancer cells. Anticancer Res.
15:2523–2527. 1995.PubMed/NCBI
|
|
31
|
Gearing AJ, Hemingway I, Pigott R, Hughes
J, Rees AJ and Cashman SJ: Soluble forms of vascular adhesion
molecules, E-selectin, ICAM-1 and VCAM-1: pathological
significance. Ann N Y Acad Sci. 667:324–331. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Olivotto IA, Bajdik CD, Ravdin PM, Speers
CH, Coldman AJ, Norris BD, Davis GJ, Chia SK and Gelmon KA:
Population-based validation of the prognostic model ADJUVANT! for
early breast cancer. J Clin Oncol. 23:2716–2725. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ravdin PM, Siminoff LA, Davis GJ, Mercer
MB, Hewlett J, Gerson N and Parker HL: Computer program to assist
in making decisions about adjuvant therapy for women with early
breast cancer. J Clin Oncol. 19:980–991. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gyorffy B, Lànczky A and Szàllàsi Z:
Implementing an online tool for genome-wide validation of
survival-associated biomarkers in ovarian-cancer using microarray
data from 1287 patients. Endocr Relat Cancer. 19:197–208. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Pénzvàltó Z, Lànczky A, Lénàrt J,
Meggyesházi N, Krenács T, Szoboszlai N, Denkert C, Pete I and
Győrffy B: MEK1 is associated with carboplatin resistance and is a
prognostic biomarker in epithelial ovarian cancer. BMC Cancer.
14:8372014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Györffy B, Benke Z, Lànczky A, Balázs B,
Szállási Z, Timár J and Schäfer R: RecurrenceOnline: An online
analysis tool to determine breast cancer recurrence and hormone
receptor status using microarray data. Breast Cancer Res Treat.
132:1025–1034. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ivanova L, Zandberga E, Silina K, Kalniņa
Z, Ābols A, Endzeliņš E, Vendina I, Romanchikova N, Hegmane A,
Trapencieris P, et al: Prognostic relevance of carbonic anhydrase
IX expression is distinct in various subtypes of breast cancer and
its silencing suppresses self-renewal capacity of breast cancer
cells. Cancer Chemother Pharmacol. 75:235–246. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tilghman SL, Townley I, Zhong Q, Carriere
PP, Zou J, Llopis SD, Preyan LC, Williams CC, Skripnikova E,
Bratton MR, et al: Proteomic signatures of acquired letrozole
resistance in breast cancer: Suppressed estrogen signaling and
increased cell motility and invasiveness. Mol Cell Proteomics.
12:2440–2455. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhou C, Zhong Q, Rhodes LV, Townley I,
Bratton MR, Zhang Q, Martin EC, Elliott S, Collins-Burow BM, Burow
ME and Wang G: Proteomic analysis of acquired tamoxifen resistance
in MCF-7 cells reveals expression signatures associated with
enhanced migration. Breast Cancer Res. 14:R452012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Nieto-Jiménez C, Alcaraz-Sanabria A, Pàez
R, Pérez-Peña J, Corrales-Sánchez V, Pandiella A and Ocaña A:
DNA-damage related genes and clinical outcome in hormone receptor
positive breast cancer. Oncotarget. 8:62834–62841. 2016.PubMed/NCBI
|
|
41
|
Lànczky A, Nagy À, Bottai G, Munkácsy G,
Szabó A, Santarpia L and Győrffy B: miR power: A web-tool to
validate survival-associated miRNAs utilizing expression data from
2178 breast cancer patients. Breast Cancer Res Treat. 160:439–446.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Szàsz AM, Lànczky A, Nagy À, Förster S,
Hark K, Green JE, Boussioutas A, Busuttil R, Szabó A and Győrffy B:
Cross-validation of survival associated biomarkers in gastric
cancer using transcriptomic data of 1,065 patients. Oncotarget.
7:49322–49333. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Shi X, Liang W, Yang W, Xia R and Song Y:
Decorin is responsible for progression of non-small-cell lung
cancer by promoting cell proliferation and metastasis. Tumour Biol.
36:3345–3354. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
You Q, Guo H and Xu D: Distinct prognostic
values and potential drug targets of ALDH1 isoenzymes in
non-small-cell lung cancer. Drug Des Devel Ther. 9:5087–5097. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Shaul YD, Yuan B, Thiru P, Nutter-Upham A,
McCallum S, Lanzkron C, Bell GW and Sabatini DM: MERAV: A tool for
comparing gene expression across human tissues and cell types.
Nucleic Acids Res. 44:D560–D566. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kanehisa M, Goto S, Sato Y, Furumichi M
and Tanabe M: KEGG for integration and interpretation of
large-scale molecular data sets. Nucleic Acids Res. 40:(Database
Issue). D109–D114. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Borentain P, Carmona S, Mathieu S, Jouve
E, El-Battari A and Gerolami R: Inhibition of E-selectin expression
on the surface of endothelial cells inhibits hepatocellular
carcinoma growth by preventing tumor angiogenesis. Cancer Chemother
Pharmacol. 77:847–856. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Ben-David T, Sagi-Assif O, Meshel T,
Lifshitz V, Yron I and Witz IP: The involvement of the sLe-a
selectin ligand in the extravasation of human colorectal carcinoma
cells. Immunol Lett. 116:218–224. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zwenger A, Rabassa M, Demichelis S,
Grossman G, Segal-Eiras A and Croce MV: High expression of sLex
associated with poor survival in Argentinian colorectal cancer
patients. Int J Biol Markers. 29:e30–e39. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Geng Y, Yeh K, Takatani T and King MR:
Three to tango: MUC1 as a ligand for both E-selectin and ICAM-1 in
the breast cancer metastatic cascade. Front Oncol. 2:762012.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Zhang GJ and Adachi I: Serum levels of
soluble intercellular adhesion molecule-1 and E-selectin in
metastatic breast carcinoma: Correlations with clinicopathological
features and prognosis. Int J Oncol. 14:71–77. 1999.PubMed/NCBI
|
|
52
|
Banks RE, Gearing AJ, Hemingway IK,
Norfolk DR, Perren TJ and Selby PJ: Circulating intercellular
adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion
molecule-1 (VCAM-1) in human malignancies. Br J Cancer. 68:122–124.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Gearing AJ and Newman W: Circulating
adhesion molecules in disease. Immunol Today. 14:506–512. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Hebbar M and Peyrat JP: Significance of
soluble endothelial molecule E-selectin in patients with breast
cancer. Int J Biol Markers. 15:15–21. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Muraki J, Kobayashi M, Sugaya Y, Hashimoto
S, Morita T, Kobayashi Y and Tokue A: Role of serum E-selectin
(ELAM-1) and inflammatory parameters in patients with renal cell
carcinoma. Nihon Hinyokika Gakkai Zasshi. 87:831–841.
1996.PubMed/NCBI
|
|
56
|
López-Miranda V, Herradón E, Gonzàlez C
and Martín MI: Vascular toxicity of chemotherapeutic agents. Curr
Vasc Pharmacol. 8:692–700. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Kaushal V, Kaushal GP and Mehta P:
Differential toxicity of anthracyclines on cultured endothelial
cells. Endothelium. 11:253–258. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Ali S, Kaur J and Patel KD: Intercellular
cell adhesion molecule-1, vascular cell adhesion molecule-1 and
regulated on activation normal T cell expressed and secreted are
expressed by human breast carcinoma cells and support eosinophil
adhesion and activation. Am J Pathol. 157:313–321. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Ogawa Y, Hirakawa K, Nakata B, Fujihara T,
Sawada T, Kato Y, Yoshikawa K and Sowa M: Expression of
intercellular adhesion molecule-1 in invasive breast cancer
reflects low growth potential, negative lymph node involvement and
good prognosis. Clin Cancer Res. 4:31–36. 1998.PubMed/NCBI
|
|
60
|
Cavusoglu Y, Timuralp B, Us T, Akgün Y,
Kudaiberdieva G, Gorenek B, Unalir A, Goktekin O and Ata N:
Cigarette smoking increases plasma concentrations of vascular cell
adhesion molecule-1 in patients with coronary artery disease.
Angiology. 55:397–402. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Mason JC, Kapahi P and Haskard DO:
Detection of increased levels of circulating intercellular adhesion
molecule 1 in some patients with rheumatoid arthritis but not in
patients with systemic lupus erythematosus. Lack of correlation
with levels of circulating vascular cell adhesion molecule 1.
Arthritis Rheum. 36:519–527. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Newman W, Beall LD, Carson CW, Hunder GG,
Graben N, Randhawa ZI, Gopal TV, Wiener-Kronish J and Matthay MA:
Soluble E-selectin is found in supernatants of activated
endothelial cells and is elevated in the serum of patients with
septic shock. J Immunol. 150:644–654. 1993.PubMed/NCBI
|
|
63
|
Guray U, Erbay AR, Güray Y, Yilmaz MB,
Boyaci AA, Sasmaz H, Korkmaz S and Kütük E: Levels of soluble
adhesion molecules in various clinical presentations of coronary
atherosclerosis. Int J Cardiol. 96:235–240. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Stenvinkel P, Lindholm B, Heimbürger M and
Heimbürger O: Elevated serum levels of soluble adhesion molecules
predict death in pre-dialysis patients: association with
malnutrition, inflammation and cardiovascular disease. Nephrol Dial
Transplant. 15:1624–1630. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Kuper H, Adami HO and Trichopoulos D:
Infections as a major preventable cause of human cancer. J Intern
Med. 248:171–183. 2000. View Article : Google Scholar : PubMed/NCBI
|
